Clinical trial
Use of Eylea for the Treatment of an Optic Nerve Hemangioma
NCT01714115 is registered in ClinicalTrials.gov with Vitreous -Retina- Macula Consultants of New York as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Eylea for the Treatment of an Optic Nerve Hemangioma
- Lead sponsor
- Vitreous -Retina- Macula Consultants of New York
- Phase
- Expanded access
- Overall status
- No longer available
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
retinal hemangioma